Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Conditions
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Medical Center, Duarte, California, United States
Contact: Principal Investigator (Alexey V. Danilov)City of Hope at Irvine Lennar, Irvine, California, United States
Contact: Principal Investigator (Alexey V. Danilov)City of Hope at Long Beach Elm, Long Beach, California, United States
Contact: Principal Investigator (Alexey V. Danilov)University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Georgios Pongas)City of Hope Atlanta Cancer Center, Newnan, Georgia, United States
Contact: Principal Investigator (Alexey V. Danilov)Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
Contact: Principal Investigator (John P. Leonard)Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Guru Subramanian Guru Murthy)
Study leads
Alexey V Danilov
Principal Investigator
City of Hope Medical Center